Antibacterial and anti-inflammatory properties of host defense peptides against Staphylococcus aureus

Journal Article (2022)
Author(s)

Leonardo Cecotto ( University Medical Centre Utrecht)

Kok van Kessel ( University Medical Centre Utrecht)

Margreet A. Wolfert (Universiteit Utrecht)

Charles Vogely ( University Medical Centre Utrecht)

Bart van der Wal ( University Medical Centre Utrecht)

Harrie Weinans (TU Delft - Biomaterials & Tissue Biomechanics, University Medical Centre Utrecht)

Jos van Strijp ( University Medical Centre Utrecht)

Saber Amin Yavari ( University Medical Centre Utrecht, Universiteit Utrecht)

DOI related publication
https://doi.org/10.1016/j.isci.2022.105211 Final published version
More Info
expand_more
Publication Year
2022
Language
English
Journal title
iScience
Issue number
10
Volume number
25
Article number
105211
Downloads counter
378
Collections
Institutional Repository
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Cationic host defense peptides (HDPs) are a promising alternative to antibiotics in the fight against Staphylococcus aureus infections. In this study, we investigated the antibacterial and immunomodulatory properties of three HDPs namely IDR-1018, CATH-2, and LL-37. Although all three HDPs significantly inhibited LPS-induced activation of human macrophages, only CATH-2 prevented S. aureus growth. When applied to different infection models focused on intracellularly surviving bacteria, only IDR-1018 showed a consistent reduction in macrophage bacterial uptake. However, this observation did not correlate with an increase in killing the efficiency of intracellular S. aureus. Here, we conclude that despite the promising antibacterial and anti-inflammatory properties of the selected HDPs, macrophages’ intrinsic antibacterial functions were not improved. Future studies should either focus on combining different HDPs or using them synergistically with other antibacterial agents to improve immune cells’ efficacy against S. aureus pathogenesis.